DK238588A - Anvendelse af 3-(trifluormethylphenoxy)-n-methyl-3-phenylpropylamin til fremstilling af et laegemiddel til behandling af diabetes - Google Patents

Anvendelse af 3-(trifluormethylphenoxy)-n-methyl-3-phenylpropylamin til fremstilling af et laegemiddel til behandling af diabetes

Info

Publication number
DK238588A
DK238588A DK238588A DK238588A DK238588A DK 238588 A DK238588 A DK 238588A DK 238588 A DK238588 A DK 238588A DK 238588 A DK238588 A DK 238588A DK 238588 A DK238588 A DK 238588A
Authority
DK
Denmark
Prior art keywords
trifluormethylphenoxy
phenylpropylamine
medicine
methyl
preparation
Prior art date
Application number
DK238588A
Other languages
English (en)
Other versions
DK238588D0 (da
Inventor
David Taiwai Wong
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK238588D0 publication Critical patent/DK238588D0/da
Publication of DK238588A publication Critical patent/DK238588A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
DK238588A 1987-05-04 1988-05-03 Anvendelse af 3-(trifluormethylphenoxy)-n-methyl-3-phenylpropylamin til fremstilling af et laegemiddel til behandling af diabetes DK238588A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4550987A 1987-05-04 1987-05-04

Publications (2)

Publication Number Publication Date
DK238588D0 DK238588D0 (da) 1988-05-03
DK238588A true DK238588A (da) 1988-11-05

Family

ID=21938301

Family Applications (1)

Application Number Title Priority Date Filing Date
DK238588A DK238588A (da) 1987-05-04 1988-05-03 Anvendelse af 3-(trifluormethylphenoxy)-n-methyl-3-phenylpropylamin til fremstilling af et laegemiddel til behandling af diabetes

Country Status (11)

Country Link
EP (1) EP0294028B1 (da)
JP (1) JP2721507B2 (da)
KR (1) KR880013555A (da)
AT (1) ATE93721T1 (da)
AU (1) AU596296B2 (da)
DE (1) DE3883606T2 (da)
DK (1) DK238588A (da)
ES (1) ES2058272T3 (da)
HK (1) HK19595A (da)
PH (1) PH23901A (da)
ZA (1) ZA883115B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2039103A1 (en) * 1990-03-29 1991-09-30 David Wayne Robertson Improvements in and relating to the selective occupation of serotonin 1c receptors
US5589511A (en) * 1990-08-13 1996-12-31 Sepracor Inc. Method for treating migraine headaches using optically pure S(+) fluoxetine
US5708035A (en) * 1991-02-04 1998-01-13 Sepracor Inc. Methods of use and compositions of R(-) fluoxetine
US5459164A (en) * 1994-02-03 1995-10-17 Boots Pharmaceuticals, Inc. Medical treatment
US7034059B2 (en) 2001-07-02 2006-04-25 Sepracor Inc. Methods of using norfluoxetine
SI2316456T1 (sl) 2003-04-29 2017-10-30 Orexigen Therapeutics, Inc. Sestavki za vplivanje na izgubo teže, ki obsegajo opioidni antagonist in bupropion
EP2135603B1 (en) 2005-11-22 2013-01-02 Orexigen Therapeutics, Inc. Compositions and methods for increasing insulin sensitivity
US8916195B2 (en) 2006-06-05 2014-12-23 Orexigen Therapeutics, Inc. Sustained release formulation of naltrexone
KR101735466B1 (ko) 2006-11-09 2017-05-15 오렉시젠 세러퓨틱스 인크. 신속하게 용해되는 중간층을 포함하는 층상의 약제학적 제형
KR20150082689A (ko) 2006-11-09 2015-07-15 오렉시젠 세러퓨틱스 인크. 단위 용량 팩키지
CA2725930A1 (en) 2008-05-30 2009-12-30 Orexigen Therapeutics, Inc. Methods for treating visceral fat conditions
CN102724878A (zh) 2010-01-11 2012-10-10 奥雷西根治疗公司 在重度抑郁症患者中提供体重减轻疗法的方法
DK3730132T3 (da) 2012-06-06 2022-08-08 Nalpropion Pharmaceuticals Llc Sammensætning til anvendelse ved en fremgangsmåde til behandling af overvægt og obesitas hos patienter med høj kardiovaskulær risiko
US20150174083A1 (en) 2012-07-31 2015-06-25 Sanovel Hayvan Sagligi Urunleri Sanayi Ve Ticaret Anonim Sirketi Use of fluoxetine for increasing meat and milk production
EA201590044A1 (ru) 2012-07-31 2015-09-30 Сановел Хайван Саглиги Юрюнлери Санайи Ве Тиджарет А.С. Применение флуоксетина у животных
US8969371B1 (en) 2013-12-06 2015-03-03 Orexigen Therapeutics, Inc. Compositions and methods for weight loss in at risk patient populations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4626549A (en) * 1974-01-10 1986-12-02 Eli Lilly And Company Treatment of obesity with aryloxyphenylpropylamines
US4018895A (en) * 1974-01-10 1977-04-19 Eli Lilly And Company Aryloxyphenylpropylamines in treating depression
US4590213A (en) * 1983-04-08 1986-05-20 Eli Lilly And Company Anti-anxiety method
CA1267092A (en) * 1985-02-25 1990-03-27 Martin D. Hynes Analgesic composition containing codeine

Also Published As

Publication number Publication date
EP0294028B1 (en) 1993-09-01
DK238588D0 (da) 1988-05-03
AU596296B2 (en) 1990-04-26
KR880013555A (ko) 1988-12-21
JP2721507B2 (ja) 1998-03-04
HK19595A (en) 1995-02-17
EP0294028A2 (en) 1988-12-07
ES2058272T3 (es) 1994-11-01
PH23901A (en) 1989-12-18
JPS63284126A (ja) 1988-11-21
ZA883115B (en) 1990-01-31
DE3883606D1 (de) 1993-10-07
EP0294028A3 (en) 1990-05-02
ATE93721T1 (de) 1993-09-15
DE3883606T2 (de) 1994-01-20
AU1553388A (en) 1988-11-10

Similar Documents

Publication Publication Date Title
DK238588D0 (da) Anvendelse af 3-(trifluormethylphenoxy)-n-methyl-3-phenylpropylamin til fremstilling af et laegemiddel til behandling af diabetes
FI883757A (fi) Terapeutiska nukleosider.
NO875022D0 (no) Apparat for medisinsk diagnostisering.
EP0143977A3 (en) Bilobalid for use as a therapeutic substance
DK159476C (da) Apparat til medicinsk behandling
FI881651A0 (fi) Terapeutiska nukleosider.
NO872924D0 (no) Fibere inneholdende legemiddel for kontrollert frigjoering.
DK49488A (da) Anaestesi-praeparat
DK472688D0 (da) Anvendelse af bezafibrat til behandling af diabetes
FI902973A0 (fi) Magnetfaeltsgenerator foer terapeutiska aendamaol.
IT8322773A0 (it) Perfezionamenti alle lenti all'infrarosso.
DK440288D0 (da) Middel til behandling af diabetes mellitus
DE3854179T2 (de) Vulkanisierbare Fluorkautschukzusammensetzung.
ES2019634B3 (es) Terapia con clorfeniramina.
DK591787A (da) Anvendelse af 5-(substitueret phenyl)-oxa-zolidinonderivater til fremstilling af et til behandling af depressioner egnet laegemiddel
FI881216A0 (fi) Terapeutiska nukleosider.
NO864320D0 (no) Harpiksblanding istand til aa avgi et bioaktivt stoff med kontrollert hastighet.
DE3861361D1 (de) Einrichtung zur herstellung von holzkohle.
IT8719036A0 (it) Composizione terapeutica per complicazioni diabetiche.
KR890004654U (ko) 해밍용 프레스 금형의 구조
ES1004102Y (es) Dispositivo emisor-receptor poliedrico de efectos terapeuticos.
IT8611760V0 (it) Siringa per l'anestesia intraligamentosa.
FI871295A0 (fi) Avlastningsanordning foer massavaror.
RO76862A2 (ro) Medicament anestezic de suprafata
IT1158737B (it) Composizione farmaceutica somministrabile per via parenterale ad azione anestetica

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment